Tele consultation and tele follow up of thyroid cancer patients: A pilot study
- 1. Dept. of Nuclear Medicine and Dept. of Endocrine Surgery, SGPGIMS, Lucknow and Dept. of Experimental Surgery, S.C.B Medical college, Cuttack (India)
Description
Full text: Radioiodine therapy is an essential component of thyroid cancer management and these patients require life long follow up at timed interval. Though radioiodine therapy is a well established adjuvant treatment for well differentiated thyroid cancer, still the acceptance by the surgical colleagues and patients is not uniform. In addition, this facility is not available in the eastern part of the country. Therefore, such patients are required to travel more than 1500 K.M. to avail this treatment and subsequent follow up at our Institution. The existing telemedicine facility between SGPGIMS, Lucknow and SCB Medical College, Cuttack provided the opportunity to utilise the system for tele-consultation and tele follow up of thyroid cancer patients. The rationale of this ongoing study is to evaluate the suitability of telemedicine for tele consultation prior to radioiodine therapy and tele follow up following radioiodine therapy of patients with well differentiated thyroid cancer. Thirty patients (10 new cases and 20 follow up cases) were included in this study. New cases were studied on the basis of case history inputs by the operating surgeon and direct patient consultation to find out their suitability for high dose radioiodine therapy. At the same time pre-therapy instructions as well as details of admission were finalised. Follow up of patients (20 in number) were discussed and examined on live along with operating surgeon with respect to compliance of thyroxine suppression therapy, local recurrence and need for further high dose radioiodine therapy. Each time, at least one surgeon and nuclear physician were involved during live evaluation of patients which was done with VSAT, broad band of 256 Kbps band width provided by ISRO, Bangalore, India and case history, radiological and nuclear medicine images were already transmitted prior to live evaluation. All ten new cases were found to be suitable for high dose radioiodine therapy. The appointment dates for their evaluation and admission could be finalised and instructions for withdrawal of thyroxin could be given to patients. Out of twenty follow up cases, only thirteen patients were required to come to SGPGIMS, Lucknow. Rest of the seven patients could be managed with instructions and need not travel to our Institution. Telemedicine has been utilised for follow up of patients in several areas. Gilmour et al emphasised the importance of telemedicine for diagnosis and management of dermatology cases referred from primary care. Fifty percent of patients could have been managed by single tele consultation without requirement of further specialist intervention. Alen et al reported the utilisation of telemedicine in cancer patients in rural areas. Redlick et al used telemedicine to evaluate patient and physician satisfaction with tele-consultations in follow up of burn cases and to assess the cost and benefit of tele-consultations. Patients were very satisfied with their tele-consultations and found them more economical and time efficient than in person visits. Telemedicine technology has been utilised for diagnosis of thyroid disorders. However, tele-consultation and tele-follow up of thyroid cancer patients before and after radioiodine therapy has never been utilised as per published literature. This telemedicine tool has strong potential for consultations of patients with thyroid cancer and monitoring them subsequently at timed interval following radioiodine treatment.In our pilot study 100% of patients consented and subsequently received radioiodine and 35% of follow up patients did not visit our Institution at Lucknow because of live interaction through telemedicine. The tele-consultation and tele-follow up of thyroid cancer patients provided great degree of patient satisfaction because of direct audio visual contact. Saving of travel expenses as well as inconvenience to travel such long distances could be achieved in 35% of cases. This is substantial both in terms of direct and indirect expenditure as well as loss of working hours for the accompanying persons as prevails in our society. The satisfaction of the operating surgeon could be achieved by discussing individual cases with regards to further follow up and management. (author)
Availability note (English)
Also available online: www.wjnm.orgAdditional details
Publishing Information
- Journal Title
- World Journal of Nuclear Medicine
- Journal Volume
- 4
- Journal Issue
- suppl.1
- Journal Page Range
- p. S36-S37
- ISSN
- 1450-1147
Conference
- Title
- International conference on radiopharmaceutical therapy
- Acronym
- ICRT-2005
- Dates
- 11-14 Oct 2005
- Place
- Limassol (Cyprus)
INIS
- Country of Publication
- International Atomic Energy Agency (IAEA)
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 36097288
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Resource subtype / Literary indicator
- Conference
- Descriptors DEI
- BRACHYTHERAPY; CARCINOMAS; DIAGNOSIS; EVALUATION; EXPENDITURES; IMAGES; NUCLEAR MEDICINE; PATIENTS; RADIATION DOSES; RURAL AREAS; SURGERY; THYROID; THYROXINE
- Descriptors DEC
- AMINO ACIDS; BODY; CARBOXYLIC ACIDS; DISEASES; DOSES; ENDOCRINE GLANDS; GLANDS; HORMONES; MEDICINE; NEOPLASMS; NUCLEAR MEDICINE; ORGANIC ACIDS; ORGANIC COMPOUNDS; ORGANIC HALOGEN COMPOUNDS; ORGANIC IODINE COMPOUNDS; ORGANS; PEPTIDE HORMONES; PROTEINS; RADIOLOGY; RADIOTHERAPY; THERAPY; THYROID HORMONES
Optional Information
- Notes
- Available in abstract form only, full text entered in this record